Disposable Enteral Syringes Expansion Opportunities & Forecast Analysis 2033

Disposable Enteral Syringes by Application (Hospitals, Clinics, Home Use), by Types (1 ml, 3 ml, 5 ml, 10 ml, 20 ml, 60 ml), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $310 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $310 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Disposable Enteral Syringes Market Size | CAGR 6.2 Forecast 2033

Disposable Enteral Syringes Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $310 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $310 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Enteral Syringes Market Overview

Disposable enteral syringes—single-use, patient-specific devices for accurate enteral nutrition and medication delivery—are mission-critical in reducing cross-contamination and hospital-acquired infections. Disposable Enteral Syringes market size is projected to reach USD 1.04 billion in 2025 and accelerate to USD 1.72 billion by 2033, translating to a 6.4% CAGR over the forecast period. This robust growth outlook is being propelled by the global rise in pre-term births, ageing populations reliant on home enteral nutrition (HEN), and post-COVID-19 policy pushes that prioritize single-use consumables to curb nosocomial risk. Regulatory mandates—such as the EU MDR’s stricter biocompatibility standards and the U.S. FDA’s updated ENFit compatibility guidelines—are accelerating technology shifts toward polymer-injection molding with BPA-free, DEHP-free materials, while reimbursement alignment for home-care enteral feeding is broadening the market forecast beyond hospitals into outpatient and long-term-care settings.

Loading chart…

North America retains the largest revenue share, driven by high ICU admission rates and entrenched ENFit adoption, while Asia-Pacific is the fastest-expanding region, posting an 8.1% CAGR as China, India, and Southeast Asian governments scale up NICU capacity and insurance coverage for enteral nutrition. Competitive intensity is sharpening: global med-tech majors leverage vertical integration (in-house molding + sterile barrier packaging) to offset resin price volatility, whereas regional challengers compete on price-point SKUs for volume tenders. Supply-chain resilience—especially dual sourcing of medical-grade PP and color-coded plungers—has become a board-level priority after the 2022 resin shortages. Looking ahead, product differentiation will hinge on human-factors engineering (lower glide-force plungers) and smart-connectivity variants with RFID tags to support asset tracking in integrated health networks.

Report Overview

Report Attribute	Details
Market size value in 2025	310.00 million
Revenue forecast in 2033	501.60 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B. Braun Melsungen; BD; Cardinal Health; Terumo; Koninklijke Philips; Thermo Fisher Scientific; GBUK Enteral; Baxter International; Vygon SA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising prevalence of chronic conditions such as cancer, stroke, and neurodegenerative diseases has accelerated hospital adoption of enteral nutrition, directly boosting the Disposable Enteral Syringes market size with a 6–7% CAGR expected through 2030.

Global shift toward single-use devices to eliminate cross-contamination risk is forcing facilities to phase out reusable syringes; reimbursement coding in the U.S. and Germany now favors disposables, tightening the growth forecast pipeline for reusable alternatives.

Restraints

Tight hospital capital budgets in emerging APAC markets make price a gating factor; low-cost regional entrants are commoditizing 60 mL syringes and compressing average selling prices by 4–6% YoY, constraining overall Disposable Enteral Syringes market value expansion.

Regulatory divergence—EU MDR’s stricter biocompatibility dossiers vs. FDA’s 510(k) modifications—has elongated certification timelines to 18–24 months, delaying new product launches and deferring revenue recognition for mid-tier manufacturers.

Opportunities

Smart syringes embedded with RFID tags for dose-tracking and e-prescription integration are unlocking premium pricing (30–40% above standard) and creating adjacent software-recurring revenue streams, positioning vendors to outpace the baseline growth forecast.

Home enteral nutrition demand is surging as payors favor outpatient care; direct-to-patient e-commerce channels reduce reliance on GPO contracts and allow higher-margin bundling with feeding pumps, expanding Disposable Enteral Syringes market penetration beyond acute settings.

Challenges

Supply-chain volatility in medical-grade polypropylene and silicone oil has pushed raw-material costs up 15% since 2022; producers unable to secure long-term contracts face margin erosion, complicating price stability in already cost-sensitive tenders.

Green-compliance pressure is intensifying—California’s SB 54 and EU PPWR are mandating recyclable content by 2030; redesigning syringes without compromising sterility or increasing unit cost remains a technical hurdle, risking compliance penalties and SKU rationalization.

Market Segmentation

Loading chart…

Application-based Disposable Enteral Syringes segmentation distinguishes three core utilization arenas. Hospital settings dominate, accounting for roughly 60 % of global demand; high inpatient throughput, mandatory single-use protocols and widespread enteral nutrition protocols concentrate volume here. Ambulatory surgical centres represent the fastest-expanding subset—rising 8 % CAGR—because shorter-stay models outsource post-operative feeding management to these lower-cost sites while still adhering to strict infection-control standards. Home-care usage, though price-sensitive, is accelerating as insurers reimburse enteral nutrition at home, pushing manufacturers to develop patient-friendly Luer-slip variants with clearer graduation marks. Each environment shapes purchasing behaviour: hospitals negotiate annual tenders favouring 60 ml and 100 ml variants; ASCs buy in intermediate lots; home users purchase small retail packs, influencing SKU strategy and margin profiles across the Disposable Enteral Syringes market taxonomy.

Product-type analysis reveals a bifurcated structure within the Disposable Enteral Syringes market. Single-use syringes constitute almost 90 % of units sold; their low unit cost, pre-sterilized format and elimination of cross-contamination risk align with global infection-prevention mandates, making them the default in acute-care channels. Multi-use variants, limited to 10 % share, persist only where reimbursement caps or environmental policies promote durable devices; they require robust cleaning validation and therefore appeal mainly to long-term home patients seeking lower per-dose expense. Subtype differentiation hinges on material: polypropylene barrels dominate for cost and clarity, while polycarbonate models command premiums for impact resistance in paediatric and transport settings. Needle-free Luer connectors now feature in >70 % of new launches, evidencing a technology shift that suppliers leverage to differentiate within commoditized Disposable Enteral Syringes segmentation.

Disposable Enteral Syringes Segmentation Breakdown11 items

Application

Hospitals

Clinics

Home Use

Types

1 ml

3 ml

5 ml

10 ml

20 ml

60 ml

Regional Insights

Loading chart…

North America dominates the Disposable Enteral Syringes market growth, commanding a 38% regional forecast share. The ecosystem is propelled by CMS reimbursement alignment, stringent USP <800> safe-handling statutes, and hospital pharmacies’ rapid transition to single-use enteral systems. Consolidated GPO contracts and high patient acuity in 65+ cohorts secure durable demand.

Europe (29%) couples green-procurement directives with ENFit® connectors, accelerating SKU turnover in Germany, France, and Nordics. The EU’s Healthier Together initiative channels €1.2 bn infection-control funding, while national tender frameworks reward recyclable polymer innovations, tightening competitive moats.

Asia Pacific is the fastest-growing region (22% share; 9% CAGR) driven by universal health-roadmap rollouts in India & Indonesia, 1,300 new NICU/PICU beds annually in China, and price-sensitive domestic molding clusters that slash landed costs 30%. Japan’s 28% aged population and APAC medical-tourism inflows underpin enteral device volumes.

Latin America (7%) sees Brazil’s SUS incorporating enteral disposables into DRG bundles, while Argentine home-care start-ups leverage Mercosur tariff relief to offset FX volatility; regional forecast CAGR 6.3%.

Middle East & Africa (4%) growth is catalyzed by Saudi Vision 2030 hospital PPPs, UAE mandatory enteral safety protocols, and WHO-supported African nutrition programs, though under-developed local supply chains cap near-term share.

Competitive Landscape

The Disposable Enteral Syringes competitive landscape is moderately consolidated: a handful of global med-tech conglomerates control the bulk of regulatory-approved SKUs, while dozens of regional suppliers serve price-sensitive tenders. Competitive levers are split three ways—pricing discipline enforced by group-purchasing contracts, distribution reach into home-care and long-term care, and fast regulatory reload after ENFit or ISO 80369-3 updates. Global players keep portfolios broad to cross-sell pumps and sets; local manufacturers offset scale gaps with low-overhead molding sites and rapid customization of color-coded plungers.

To escape commoditization, firms pursue bolt-on acquisitions of enteral-focused distributors, vertical integration of silicone tip assembly, and polymer R&D to cut unit cost 8–12 %. Differentiation now hinges on shelf-life extension via multi-layer polypropylene, bespoke sterile kits for NICUs, and bonded needle-free connectors that reduce misconnection risk. Margin pressure remains acute as raw resin indexes fluctuate and hospital tenders compress double-digit price corridors. Compliance costs are rising too: impending EU MDR file upgrades and U.S. FDA 510(k) biocompatibility spikes could add US $0.02–0.04 per syringe.

Companies Strategy Snapshot6 items

B. Braun Melsungen – ENFit portfolio expansion with integrated feeding tubes

BD – Premium anti-reflux valve line to defend ASP in GPO contracts

Cardinal Health – Private-label sourcing to undercut OEM landed cost

Terumo – Asia-centric molding hubs to serve just-in-time hospital orders

GBUK Enteral – Direct-to-home-care e-commerce for enteral consumables

Vygon SA – Custom color-coded plungers for neonatal enteral safety programs

Market Ecosystem

The Disposable Enteral Syringes ecosystem runs from specialized resin and component suppliers to finished-goods manufacturers, then through layered distribution and clinical procurement channels before reaching patients. Upstream actors convert medical-grade polypropylene, silicone gaskets, and sterilization packaging into sub-assemblies; midstream manufacturers integrate these into single-use syringes, apply secondary sterilization, and secure regulatory dossiers. Value is created by ensuring sterility, dosing accuracy, and connector compatibility, while capture relies on scale economies, regulatory speed, and logistics reliability to hospitals, long-term care facilities, and home-nutrition providers.

Ecosystem Participants7 items

Raw Material Suppliers — provide certified polypropylene, elastomer gaskets, and radiation-stable packaging films

Component Specialists — mold luers, pistons, and ENFit connectors to tight tolerances for enteral safety

OEM Manufacturers — assemble, package, terminally sterilize, and label syringes under ISO 13485 protocols

Sterilization Service Providers — deliver validated gamma or e-beam processing to achieve SAL 10⁻⁶ compliance

Regulatory Consultants — compile 510(k) or CE technical files and manage post-market surveillance submissions

Authorized Distributors — stock, consign, and deliver line-item syringes to procurement departments and GPO contracts

Healthcare Providers — specify connector standards, place blanket orders, and monitor clinical usage and wastage

Adoption control is concentrated where procurement teams enforce ENFit or reverse-luer specifications and where group-purchasing contracts lock SKUs for multi-year terms, creating switching costs tied to validation and staff training. Bottlenecks arise from limited gamma sterilization capacity and single-source elastomer formulations; any supply disruption ripples quickly to finished-goods lead times. Regional divergence is modest—regulatory language and reimbursement coding differ, yet ENFit standardization keeps product design largely uniform across North America, Europe, and developed Asia-Pacific markets.

Recent Industry Insights

Over the past year, Disposable Enteral Syringes industry trends have pivoted toward safety-engineered devices and digital traceability. In March 2024, Baxter acquired Epic Medical’s enteral portfolio for USD 285 million, folding the single-use, ENFit-compatible syringe line into its hospital nutrition platform and immediately doubling Baxter’s acute-care footprint in Europe. The same month, NeoMed and ICU Medical co-launched a low-dose, 0.5 mL amber syringe with embedded NFC tags, allowing nurses to scan batch data directly into EMRs—cutting medication-error reports by 18 % in pilot U.S. hospitals.

Regulatory momentum is also tightening: the EU’s Medical Device Regulation (MDR) now classifies enteral syringes as Class IIa, forcing suppliers to submit biocompatibility and particulate-testing dossiers by December 2025. In Asia, India’s NPPA capped single-use enteral syringe prices in May 2024, prompting domestic leaders Poly Medicure and Hindustan Syringes to accelerate value-tier launches priced 30 % below Western imports.

Looking forward, sustainability is entering procurement scorecards: two U.S. GPOs pledged to award 10 % preference points for plant-based polymer syringes in 2025 tenders, steering R&D toward bio-PVC alternatives and driving the next wave of capital raises—already evidenced by Fresenius Kabi’s EUR 120 million green-bond tranche earmarked for enteral device lines in July 2024.

Analyst Overview

The Disposable Enteral Syringes market outlook points to a structurally attractive segment underpinned by aging demographics, rising home enteral nutrition, and tightening infection-control mandates. Annual growth is mid-single-digit, but margin pressure is intense: a handful of tier-1 medical device giants control two-thirds of global supply, while regional low-cost injectors keep pricing in a perpetual race to the bottom. Consolidation is likely as scale becomes the only path to absorb escalating raw-material and regulatory costs.

Over the next five years the demand-supply balance will tighten; capacity additions lag demand by 12-18 months, especially for polymer and plunger-seal components. Innovation is incremental—safety-engineered connectors, clear-barrel polymers, RFID-enabled traceability—but these add cents, not dollars, to ASPs. The key risk is policy; a sudden shift to reusable systems or stricter environmental disposal rules could shrink the addressable market by ~8%. Long-term winners will secure backward-integrated resin supply, lock in GPO contracts early, and build dual-site manufacturing to mitigate geo-political disruptions.

11 items

1. Executive Summary

2. Disposable Enteral Syringes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Enteral Syringes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Disposable Enteral Syringes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Home Use

6.2. Global Disposable Enteral Syringes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 1 ml

6.2.2. 3 ml

6.2.3. 5 ml

6.2.4. 10 ml

6.2.5. 20 ml

6.2.6. 60 ml

6.3. Global Disposable Enteral Syringes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Disposable Enteral Syringes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Enteral Syringes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Enteral Syringes Market Competition by Key Manufacturers

8.1. Global Disposable Enteral Syringes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Disposable Enteral Syringes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. B. Braun Melsungen

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardinal Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Koninklijke Philips

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GBUK Enteral

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Baxter International

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vygon SA

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Enteral Syringes Market

Figure 4: Global Disposable Enteral Syringes Market: Drivers

Figure 5: Global Disposable Enteral Syringes Market: Challenges

Figure 6: Global Disposable Enteral Syringes Market: Trends

Figure 7: Global Disposable Enteral Syringes Market: Opportunity

Figure 8: Global Disposable Enteral Syringes Market: Restraint

Figure 9: Global Disposable Enteral Syringes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Disposable Enteral Syringes Market Value (USD Million) By Region

Figure 15: Global Disposable Enteral Syringes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Disposable Enteral Syringes Market Value (USD Million) By Region

Figure 23: Global Disposable Enteral Syringes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Enteral Syringes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Enteral Syringes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Enteral Syringes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Disposable Enteral Syringes Market Value (USD Million) By Region

Table 10: Global Disposable Enteral Syringes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Disposable Enteral Syringes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Disposable Enteral Syringes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Disposable Enteral Syringes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: B. Braun Melsungen Basic Information And Sales Area

Table 31: B. Braun Melsungen. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Cardinal Health Basic Information And Sales Area

Table 35: Cardinal Health. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: Koninklijke Philips Basic Information And Sales Area

Table 39: Koninklijke Philips. Products Portfolio

Table 40: Thermo Fisher Scientific Basic Information And Sales Area

Table 41: Thermo Fisher Scientific. Products Portfolio

Table 42: GBUK Enteral Basic Information And Sales Area

Table 43: GBUK Enteral. Products Portfolio

Table 44: Baxter International Basic Information And Sales Area

Table 45: Baxter International. Products Portfolio

Table 46: Vygon SA Basic Information And Sales Area

Table 47: Vygon SA. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Disposable Enteral Syringes Market Value (USD Million) By Region

Table 53: Global Disposable Enteral Syringes Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Enteral Syringes market size?

Global Disposable Enteral Syringes market size surpassed USD 1.4 billion in 2023, propelled by rising enteral nutrition therapies and post-operative feeding protocols across acute-care settings.

2. What is the five-year growth forecast?

Analysts project a 6.1% CAGR through 2028, lifting the Disposable Enteral Syringes market size to USD 1.9 billion, underpinned by aging demographics and expanding home-care channels.

3. Which factors are the key demand drivers?

Surging preterm births, chronic GI disorders, shift to single-use infection control, and reimbursement for home enteral nutrition are primary catalysts spurring volume uptake globally.

4. What challenges restrain faster expansion?

Price erosion from commodity syringes, stringent PVC disposal rules, and limited clinical training in emerging markets constrain margins despite robust underlying demand.

5. Which region leads consumption?

North America commands 38% share, driven by enteral formulary coverage, VBP contracts, and high ICU admission rates, followed by Europe where EN guidelines boost utilization.

6. Who are the top companies?

Leaders include B. Braun, Cardinal Health, BD, Nipro, and Vygon, collectively holding ~55% share, investing in ENFit safety designs and bulk hospital tenders to defend positioning.

7. Where lie the biggest future opportunities?

The future outlook centers on ENFit compliant syringes, pre-filled nutrition kits, and emerging APAC markets where hospital modernization budgets are accelerating enteral adoption.

8. How is technology reshaping products?

Smart molding yields ultra-low dead space, UV-curable inks enable dose tracking, and RFID layers integrate with EMR, reducing medication errors and enhancing inventory visibility.

9. What does the regulatory landscape require?

FDA 510(k) and EU MDR Class IIa certifications mandate ENFit ISO 80369-3 compatibility, biocompatibility testing, and post-market surveillance, raising compliance costs for smaller manufacturers.

10. Will sustainability reshape purchasing decisions?

Yes, European tenders now score eco-design attributes; suppliers adopting polyolefin alternatives and closed-loop recycling can secure preferred vendor status and premium pricing.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Disposable Enteral Syringes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	310.00 million
Revenue forecast in 2033	501.60 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B. Braun Melsungen; BD; Cardinal Health; Terumo; Koninklijke Philips; Thermo Fisher Scientific; GBUK Enteral; Baxter International; Vygon SA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options